Multifunctional applications and research advances of low-molecular-weight heparin
Low-molecular-weight heparin (LMWH) is a class of anticoagulant drugs derived from the controlled depolymerization of heparin. LMWH possesses a lower molecular weight and a shorter glycan chain length than unfractionated heparin (UFH), resulting in higher bioavailability, a more predictable pharmaco...
Saved in:
| Main Authors: | Yanru Zhang, Shuixian Guo, Jingchao Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1585762/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of low molecular weight heparin on cancer patients’ survival
by: V. V. Ptushkin
Published: (2014-07-01) -
International normalized ratio measurement during perioperative anticoagulation bridging with low-molecular-weight heparin in patients undergoing heart valve replacement surgery
by: Liza Rijvers, et al.
Published: (2024-11-01) -
Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01) -
Pharmacokinetics of low molecular weight heparins in thrombosis, complicate the treatment of children with cancer
by: V. V. Dmitriev, et al.
Published: (2021-04-01) -
The methods of assessment of quality and safety of medicaments on the basis of low molecular weight heparins
by: E. A. Arianova, et al.
Published: (2011-09-01)